The new product reportedly boasts remarkable mechanical properties, along with outstanding biocompatibility. The Company's exclusive range of products, Hastalex and BioHastalex, are only available to its existing customer base.
In a recent interview, Goodfellow Cambridge’s CEO, Simon Kenney, also mentioned that the Company is a member of the BSI UK graphene group. The group aims to “conduct research into how standards can help support UK innovators accelerate the rate of commercialization of graphene applications”.
Read the original article on Graphene-Info.
